ERBB2 and neoplasm: This study also identifies that osterix expression levels are associated with survival of patients with HER2 positive tumours rather than HER2 negative tumours; whilst it is unclear why this is the case, osterix can be activated by ERK signalling, which is activated downstream of HER2.